Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kian Ang

Showing results (181-190 of 206) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|June 10, 2010
Human papillomavirus and survival of patients with oropharyngeal cancerK Kian Ang, Jonathan Harris, Richard Wheeler, et al.
Cancer|January 15, 2015
Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade surveyDavid I Rosenthal, Abdallah S R Mohamed, Randal S Weber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2013
An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinomaQuynh-Thu Le, Qiang Zhang, Hongbin Cao, et al.
The New England Journal of Medicine|February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckJames A Bonner, Paul M Harari, Jordi Giralt, et al.
Nature Cell Biology|August 4, 2014
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1Peijing Zhang, Yongkun Wei, Li Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapyBenjamin J Moeller, John S Yordy, Michelle D Williams, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neckJay S Cooper, Qiang Zhang, Thomas F Pajak, et al.
Cell Research|January 21, 2015
Tyrosine 370 phosphorylation of ATM positively regulates DNA damage responseHong-Jen Lee, Li Lan, Guang Peng, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Cancer|May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)K Kian Ang, Amy Chen, Walter J Curran, et al.
Pageof 21

Showing results (181-190 of 206) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|June 10, 2010
Human papillomavirus and survival of patients with oropharyngeal cancerK Kian Ang, Jonathan Harris, Richard Wheeler, et al.
Cancer|January 15, 2015
Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade surveyDavid I Rosenthal, Abdallah S R Mohamed, Randal S Weber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2013
An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinomaQuynh-Thu Le, Qiang Zhang, Hongbin Cao, et al.
The New England Journal of Medicine|February 10, 2006
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckJames A Bonner, Paul M Harari, Jordi Giralt, et al.
Nature Cell Biology|August 4, 2014
ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1Peijing Zhang, Yongkun Wei, Li Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapyBenjamin J Moeller, John S Yordy, Michelle D Williams, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2012
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neckJay S Cooper, Qiang Zhang, Thomas F Pajak, et al.
Cell Research|January 21, 2015
Tyrosine 370 phosphorylation of ATM positively regulates DNA damage responseHong-Jen Lee, Li Lan, Guang Peng, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancyAndy Trotti, Adam Garden, Padraig Warde, et al.
Cancer|May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)K Kian Ang, Amy Chen, Walter J Curran, et al.
Pageof 21